Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease

被引:88
|
作者
Valenza, M. [1 ,2 ]
Marullo, M. [1 ,2 ]
Di Paolo, E. [1 ,2 ]
Cesana, E. [3 ]
Zuccato, C. [1 ,2 ]
Biella, G. [3 ]
Cattaneo, E. [1 ,2 ]
机构
[1] Univ Milan, Dept Biosci, I-20133 Milan, Italy
[2] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy
[3] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy
来源
CELL DEATH AND DIFFERENTIATION | 2015年 / 22卷 / 04期
关键词
CENTRAL-NERVOUS-SYSTEM; GLIAL-CELLS; MUTANT HUNTINGTIN; MOUSE MODEL; PLASMA; 24S-HYDROXYCHOLESTEROL; BIOSYNTHESIS PATHWAY; EXPRESSION; DYSFUNCTION; METABOLISM; MANIFEST;
D O I
10.1038/cdd.2014.162
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the adult brain, neurons require local cholesterol production, which is supplied by astrocytes through apoE-containing lipoproteins. In Huntington's disease (HD), such cholesterol biosynthesis in the brain is severely reduced. Here we show that this defect, occurring in astrocytes, is detrimental for HD neurons. Astrocytes bearing the huntingtin protein containing increasing CAG repeats secreted less apoE-lipoprotein-bound cholesterol in the medium. Conditioned media from HD astrocytes and lipoprotein-depleted conditioned media from wild-type (wt) astrocytes were equally detrimental in a neurite outgrowth assay and did not support synaptic activity in HD neurons, compared with conditions of cholesterol supplementation or conditioned media from wt astrocytes. Molecular perturbation of cholesterol biosynthesis and efflux in astrocytes caused similarly altered astrocyte-neuron cross talk, whereas enhancement of glial SREBP2 and ABCA1 function reversed the aspects of neuronal dysfunction in HD. These findings indicate that astrocyte-mediated cholesterol homeostasis could be a potential therapeutic target to ameliorate neuronal dysfunction in HD.
引用
收藏
页码:690 / 702
页数:13
相关论文
共 50 条
  • [31] PGC-1α at the intersection of bioenergetics regulation and neuron function: From Huntington's disease to Parkinson's disease and beyond
    Tsunemi, Taiji
    La Spada, Albert R.
    PROGRESS IN NEUROBIOLOGY, 2012, 97 (02) : 142 - 151
  • [32] Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
    Valenza, Marta
    Chen, Jane Y.
    Di Paolo, Eleonora
    Ruozi, Barbara
    Belletti, Daniela
    Bardile, Costanza Ferrari
    Leoni, Valerio
    Caccia, Claudio
    Brilli, Elisa
    Di Donato, Stefano
    Boido, Marina M.
    Vercelli, Alessandro
    Vandelli, Maria A.
    Forni, Flavio
    Cepeda, Carlos
    Levine, Michael S.
    Tosi, Giovanni
    Cattaneo, Elena
    EMBO MOLECULAR MEDICINE, 2015, 7 (12) : 1547 - 1564
  • [33] Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair
    Marchetti, Bianca
    L'Episcopo, Francesca
    Morale, Maria Concetta
    Tirolo, Cataldo
    Testa, Nuccio
    Caniglia, Salvo
    Serapide, Maria Francesca
    Pluchino, Stefano
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2013, 37 (10) : 1550 - 1563
  • [34] Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's disease
    Zhou, Lan -Ting
    Liu, Dan
    Kang, Hui-Cong
    Lu, Lu
    Huang, He-Zhou
    Ai, Wen-Qing
    Zhou, Yang
    Deng, Man-Fei
    Li, Hao
    Liu, Zhi-Qiang
    Zhang, Wei-Feng
    Hu, Ya-Zhuo
    Han, Zhi-Tao
    Zhang, Hong -Hong
    Jia, Jian-Jun
    Sarkar, Avijite Kumer
    Sharaydeh, Saldin
    Wang, Jie
    Man, Heng-Ye
    Schilling, Marcel
    Bertram, Lars
    Lu, Youming
    Guo, Ziyuan
    Zhu, Ling-Qiang
    SCIENCE ADVANCES, 2023, 9 (16)
  • [35] Disruption of the astrocyte–neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer’s disease animal model
    Moonseok Choi
    Sang-Min Lee
    Dongsoo Kim
    Heh-In Im
    Hye-Sun Kim
    Yun Ha Jeong
    Molecular Brain, 14
  • [36] Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease
    Beggiato, Sarah
    Cassano, Tommaso
    Ferraro, Luca
    Tomasini, Maria C.
    LIFE SCIENCES, 2020, 257
  • [37] PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically
    Dickey, Audrey S.
    Pineda, Victor V.
    Tsunemi, Taiji
    Liu, Patrick P.
    Miranda, Helen C.
    Gilmore-Hall, Stephen K.
    Lomas, Nicole
    Sampat, Kunal R.
    Buttgereit, Anne
    Torres, Mark-Joseph Manalang
    Flores, April L.
    Arreola, Martin
    Arbez, Nicolas
    Akimov, Sergey S.
    Gaasterland, Terry
    Lazarowski, Eduardo R.
    Ross, Christopher A.
    Yeo, Gene W.
    Sopher, Bryce L.
    Magnuson, Gavin K.
    Pinkerton, Anthony B.
    Masliah, Eliezer
    La Spada, Albert R.
    NATURE MEDICINE, 2016, 22 (01) : 37 - +
  • [38] PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically
    Audrey S Dickey
    Victor V Pineda
    Taiji Tsunemi
    Patrick P Liu
    Helen C Miranda
    Stephen K Gilmore-Hall
    Nicole Lomas
    Kunal R Sampat
    Anne Buttgereit
    Mark-Joseph Manalang Torres
    April L Flores
    Martin Arreola
    Nicolas Arbez
    Sergey S Akimov
    Terry Gaasterland
    Eduardo R Lazarowski
    Christopher A Ross
    Gene W Yeo
    Bryce L Sopher
    Gavin K Magnuson
    Anthony B Pinkerton
    Eliezer Masliah
    Albert R La Spada
    Nature Medicine, 2016, 22 : 37 - 45
  • [39] TRIAD OF NEURONAL VULNERABILITY IN HUNTINGTON'S DISEASE: HUNTINGTIN PROTEOSTASIS, INCLUSION BODY FORMATION AND MITOCHONDRIAL FUNCTION
    Soares, Tapia R.
    Pinho, Brigida R.
    Duchen, Michael R.
    Oliveira, Jorge M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A14 - A14
  • [40] Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington's Disease
    Shawki, Samar M.
    Saad, Mohammed A.
    Rahmo, Rania M.
    Wadie, Walaa
    El-Abhar, Hanan S.
    FRONTIERS IN PHARMACOLOGY, 2021, 12